Almost 40% of HGGs in children relate to alterations in the p53, and in contrast to high-grade gliomas in adults, those HGGs in childhood have been correlated with improved 5-year progression-free survival (PFS) [89]. The gene discussed is TP53; the disease is central nervous system cancer.